Hatrongjit Rujirat, Akeda Yukihiro, Hamada Shigeyuki, Gottschalk Marcelo, Kerdsin Anusak
Faculty of Science and Engineering, Kasetsart University Chalermphrakiat Sakon Nakhon Province Campus, Sakon Nakhon, Thailand.
Osaka University Hospital, Osaka University, Osaka, Japan.
J Med Microbiol. 2017 Nov;66(11):1590-1595. doi: 10.1099/jmm.0.000615. Epub 2017 Oct 12.
The aim of this study was to develop a multiplex PCR (mPCR) for simultaneous detection (single reaction) of six clinically relevant streptococcal species: Streptococcus pneumoniae, Streptococcus suis, Streptococcus gallolyticus subsp. gallolyticus, S. gallolyticus subsp. pasteurianus, Streptococcus intermedius and Streptococcus anginosus/constellatus.
mPCR with primers specific for S. pneumoniae (lytA), S. suis (recN), S. gallolyticus subsp. gallolyticus (tanB), S. gallolyticus subsp. pasteurianus (SGPB0680 cell wall surface protein), S. intermedius (ily) and S. anginosus/constellatus (moaC) was employed with 37 reference bacterial strains and 442 clinical streptococcal isolates collected from seven tertiary hospitals in north-east Thailand. Results from this mPCR were compared to those obtained with the API 20 Strep and conventional biochemical tests.
The six clinically relevant streptococcal species gave the expected amplification products of 229, 362, 531, 723, 819 and 978 bp for S. pneumoniae, S. gallolyticus subsp. gallolyticus, S. gallolyticus subsp. pasteurianus, S. suis, S. intermedius and S. anginosus/S. constellatus, respectively. Non-specific reactions were not observed with the other bacterial species tested. For the 442 clinical streptococci, this mPCR assay confirmed the identity of the species in accordance with results obtained with the API 20 Strep and conventional biochemical tests.
This mPCR can be applied to the rapid identification of pure cultures of these six streptococci. The test was shown to be rapid, simple and reliable for the identification of these streptococci at the species level. This assay should be useful for laboratory identification and surveillance of human infections by these bacterial species.
本研究的目的是开发一种多重聚合酶链反应(mPCR),用于同时检测(单一反应)六种临床相关的链球菌:肺炎链球菌、猪链球菌、解脲链球菌解脲亚种、解脲链球菌巴氏亚种、中间链球菌和咽峡炎链球菌/星座链球菌。
使用针对肺炎链球菌(lytA)、猪链球菌(recN)、解脲链球菌解脲亚种(tanB)、解脲链球菌巴氏亚种(SGPB0680细胞壁表面蛋白)、中间链球菌(ily)和咽峡炎链球菌/星座链球菌(moaC)的特异性引物进行mPCR,对从泰国东北部七家三级医院收集的37株参考菌株和442株临床链球菌分离株进行检测。将该mPCR的结果与使用API 20 Strep和传统生化试验获得的结果进行比较。
六种临床相关的链球菌分别产生了预期的扩增产物,肺炎链球菌、解脲链球菌解脲亚种、解脲链球菌巴氏亚种、猪链球菌、中间链球菌和咽峡炎链球菌/星座链球菌的扩增产物大小分别为229、362、531、723、819和978 bp。在所检测的其他细菌物种中未观察到非特异性反应。对于442株临床链球菌,该mPCR检测根据使用API 20 Strep和传统生化试验获得的结果确认了物种身份。
该mPCR可用于快速鉴定这六种链球菌的纯培养物。该检测方法在物种水平上对这些链球菌的鉴定显示出快速、简单且可靠。该检测方法应有助于实验室对这些细菌物种引起的人类感染进行鉴定和监测。